Oncotelic Therapeutics, Inc. (OTC:OTLC) filed a Form 8-K with the Securities and Exchange Commission on January 26, 2026, disclosing a material event.
Oncotelic Therapeutics, Inc.'s stock currently trades at $0.08 with a market capitalization of $39.8M. The Healthcare company's stock moved following the disclosure.